| 3BP | 3-bromopyruvate |
| BPTES | bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide |
| CDK | cyclin-dependent kinase |
| CDKN2A | cyclin-dependent kinase inhibitor 2A |
| CTLA-4 | cytotoxic T lymphocyte antigen-4 |
| DOPC | 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine |
| EAA | essential amino acid |
| EIPA | 5-(N-ethyl-N-isopropyl)amiloride |
| ER | Endoplasmic Reticulum |
| FBLD | fragment-based lead discovery |
| FTase | farnesyltransferase |
| FTI | farnesyl transferase inhibitor |
| FTS | farnesyl thiosalicylic acid |
| GAP | GTPase activating proteins |
| GDP | guanosine diphosphate |
| GEF | guanine nucleotide exchange factors |
| GTP | guanosine triphosphate |
| HA | hyaluronic acid |
| HBS | hydrogen bond surrogate |
| HCQ | hydroxychloroquine |
| Hk1 | hexokinase 1 |
| Hk2 | hexokinase 2 |
| ICMT | isoprenylcysteine methyltransferase |
| LDHA | lactate dehydrogenase A |
| LODER | Local Drug EluteR |
| MHC | major histocompatibility complexes |
| mTOR | mammalian target of rapamycin |
| mTORC1 | mTOR complex 1 |
| mTORC2 | mTOR complex 2 |
| NSCLC | Non-small cell lung cancer |
| PanIN | pancreatic intraepithelial neoplasia |
| PDAC | Pancreatic Ductal Adenocarcinoma |
| PDEδ | Phosphodiesterase δ |
| Pfk1 | phosphofructokinase |
| PFS | progression free survival |
| PH | pleckstrin homology |
| PIP2 | phosphatidylinositol 4,5-bisphosphate |
| PKC | protein kinase C |
| PPP | pentose phosphate pathway |
| RCE1 | RAS converting enzyme 1 |
| RNAi | RNA interference |
| Serine 181 | S181 |
| SOS | Son of Sevenless |
| TP53 | tumor protein 53 |